• Data
  • Studio
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Governance
    • Events
    • Newsroom
    • Careers
Contact Us

Sign In

  • Data
  • Studio
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Governance
    • Events
    • Newsroom
    • Careers
Truveta and Alpine Immune Sciences announce strategic partnership to access Truveta’s community to accelerate recruitment to povetacicept clinical trials

Truveta and Alpine Immune Sciences announce strategic partnership to access Truveta’s community to accelerate recruitment to povetacicept clinical trials

by Truveta Staff | Mar 22, 2023 | News

Today, Truveta and Alpine Immune Sciences, Inc. announced a strategic partnership to help accelerate clinical trial recruitment for povetacicept, Alpine’s dual B cell cytokine antagonist being developed for multiple B cell-mediated autoimmune and inflammatory...
Building Truveta’s product is a passion project for Engineering Director Denesh Pohar

Building Truveta’s product is a passion project for Engineering Director Denesh Pohar

by Truveta Staff | Oct 12, 2021 | Culture

For Denesh Pohar, Truveta’s vision of Saving Lives with Data is easy to get excited about — and a big responsibility. We sat down with Denesh to learn more about his experience and his motivation as a director of engineering at Truveta, to make data more...

Share this


Recent posts

  • Advancing epilepsy research: Insights from Truveta’s epilepsy data
  • Truveta and Mathematica partner to advance public health and health equity with real-world data
  • Medical Components, Inc. and Truveta: Using real-world data to improve patient care

Follow Truveta


Stay up-to-date

Ready to join us on our mission of Saving Lives with Data?

Get started
  • Follow
  • Follow

Truveta Data

Truveta Studio

Research

Resources

Blog

Leadership

Governance

Newsroom

Careers

Contact us

Privacy Notice

© Truveta 2023

Interested in learning more?

Reach out and we’ll schedule a demo.